Five-year Efficacy and Safety of Tocilizumab Monotherapy in Patients with Rheumatoid Arthritis Who Were Methotrexate- and Biologic-naive or Free of Methotrexate for 6 Months: the AMBITION Study - Concepedia

Concepedia

Publication | Closed Access

Five-year Efficacy and Safety of Tocilizumab Monotherapy in Patients with Rheumatoid Arthritis Who Were Methotrexate- and Biologic-naive or Free of Methotrexate for 6 Months: the AMBITION Study

38

Citations

9

References

2016

Year

Graeme Jones, Thomas W. Wallace, Matthew J. McIntosh, Laura Brockwell, Juan J. Gómez‐Reino, Anthony Sebba

The Journal of Rheumatology

Abstract

Longterm monotherapy with TCZ demonstrated continuing efficacy and safety.

References

	Year	Citations

Page 1